Clinical Trial Update: Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled study evaluated the efficacy and safety of vortioxetine at 15 mg and 20 mg in adults with acute major depressive disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (Lu AA21004) (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-11